666

SENHWA BIOSCIENCES INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪3.65 B‬TWD
−3.30TWD
‪−296.31 M‬TWD
‪1.00 M‬TWD
‪58.09 M‬
Beta (1Y)
0.03

About SENHWA BIOSCIENCES INC

CEO
Tai Sen Soong
Headquarters
New Taipei
Founded
2012
ISIN
TW0006492002
FIGI
BBG007LX9HL8
Senhwa Biosciences, Inc. engages in the research and development of anticancer drug and active pharmaceutical ingredient. It has two agents in clinical development for cancer, which includes CX-5461, a compound that activates p53 and kills cancer cells; and CX-4945, a compound that controls the growth and proliferation of cancer cells. The company was founded by Tai Sen Soong on November 16, 2012 and is headquartered in New Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6492 is 41.30 TWD — it has increased by 1.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange SENHWA BIOSCIENCES INC stocks are traded under the ticker 6492.
SENHWA BIOSCIENCES INC is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6492 stock is 2.70% volatile and has beta coefficient of 0.03. Check out the list of the most volatile stocks — is SENHWA BIOSCIENCES INC there?
Yes, you can track SENHWA BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
6492 stock has risen by 1.35% compared to the previous week, the month change is a 5.06% fall, over the last year SENHWA BIOSCIENCES INC has showed a 17.89% decrease.
6492 net income for the last quarter is ‪−83.59 M‬ TWD, while the quarter before that showed ‪−75.14 M‬ TWD of net income which accounts for −11.25% change. Track more SENHWA BIOSCIENCES INC financial stats to get the full picture.
Today SENHWA BIOSCIENCES INC has the market capitalization of ‪3.63 B‬, it has decreased by 1.45% over the last week.
No, 6492 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6492 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SENHWA BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
6492 reached its all-time high on Sep 11, 2020 with the price of 309.50 TWD, and its all-time low was 38.85 TWD and was reached on Oct 25, 2022.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SENHWA BIOSCIENCES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SENHWA BIOSCIENCES INC stock shows the sell signal. See more of SENHWA BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SENHWA BIOSCIENCES INC EBITDA is ‪−300.39 M‬ TWD, and current EBITDA margin is ‪−30.04 K‬%. See more stats in SENHWA BIOSCIENCES INC financial statements.